HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Immunogenicity and Protective Efficacy of T-Cell Epitopes Derived From Potential Th1 Stimulatory Proteins of Leishmania (Leishmania) donovani.

Abstract
Development of a suitable vaccine against visceral leishmaniasis (VL), a fatal parasitic disease, is considered to be vital for maintaining the success of kala-azar control programs. The fact that Leishmania-infected individuals generate life-long immunity offers a viable proposition in this direction. Our prior studies demonstrated that T-helper1 (Th1) type of cellular response was generated by six potential recombinant proteins viz. elongation factor-2 (elF-2), enolase, aldolase, triose phosphate isomerase (TPI), protein disulfide isomerase (PDI) and p45, derived from a soluble antigenic fraction (89.9-97.1 kDa) of Leishmania (Leishmania) donovani promastigote, in treated Leishmania patients and golden hamsters and showed significant prophylactic potential against experimental VL. Moreover, since, it is well-known that our immune system, in general, triggers production of specific protective immunity in response to a small number of amino acids (peptide), this led to the identification of antigenic epitopes of the above-stated proteins utilizing immunoinformatics. Out of thirty-six, three peptides-P-10 (enolase), P-14, and P-15 (TPI) elicited common significant lymphoproliferative as well as Th1-biased cytokine responses both in golden hamsters and human subjects. Further, immunization with these peptides plus BCG offered 75% prophylactic efficacy with boosted cellular immune response in golden hamsters against Leishmania challenge which is indicative of their candidature as potential vaccine candidates.
AuthorsSumit Joshi, Narendra Kumar Yadav, Keerti Rawat, Vikash Kumar, Rafat Ali, Amogh Anant Sahasrabuddhe, Mohammad Imran Siddiqi, Wahajul Haq, Shyam Sundar, Anuradha Dube
JournalFrontiers in immunology (Front Immunol) Vol. 10 Pg. 288 ( 2019) ISSN: 1664-3224 [Electronic] Switzerland
PMID30873164 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Cytokines
  • Epitopes, T-Lymphocyte
  • Leishmaniasis Vaccines
  • Protozoan Proteins
Topics
  • Animals
  • Cricetinae
  • Cytokines (blood)
  • Epitopes, T-Lymphocyte (immunology)
  • Leishmania donovani (immunology)
  • Leishmaniasis Vaccines (immunology)
  • Lymphocyte Activation
  • Mesocricetus
  • Protozoan Proteins (immunology)
  • Spleen (immunology)
  • Th1 Cells (immunology)
  • Vaccination

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: